Iberogast

Milk Thistle Fruit Extract, the active ingredient in Iberogast, is a herbal combination presented as an oral liquid (drops) for oral use. It treats functional dyspepsia, irritable bowel syndrome, gastro‑oesophageal reflux disease and related gastrointestinal disorders in adults.

GNH USA supplies Iberogast as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iberogast is indicated for several functional gastrointestinal disorders and works by modulating motility and inflammation.

Functional dyspepsia: alleviates upper abdominal discomfort and post‑prandial fullness. Irritable bowel syndrome: reduces abdominal pain and normalises bowel habits. Gastro‑oesophageal reflux disease: lessens heartburn and regurgitation episodes. Gastric motility disorders: improves gastric emptying and reduces bloating.

Iberogast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Altered taste sensation - Mild diarrhoea - Nausea - Abdominal cramps - Flatulence - Headache

Serious or Rare Side Effects: - Allergic reactions including rash or urticaria - Hepatic enzyme elevation - Severe skin reactions such as Stevens‑Johnson syndrome - Anaphylaxis - Eosinophilic colitis (rare) - Hepatotoxicity in susceptible individuals

Before using Iberogast, consider the following safety measures.

Pregnancy: safety not established; avoid unless advised by a physician. Breastfeeding: insufficient data; use with caution. Age: not recommended for children under 12 years. Liver disease: monitor hepatic function during therapy. Drug interactions: discuss all concurrent medications with a healthcare professional. Store at ambient temperature: keep in the original container, protect from moisture and light.

Iberogast may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Cytochrome P450 substrates: potential inhibition may increase plasma levels. - Anticoagulants: additive effect may raise bleeding risk. - Immunosuppressants: possible alteration of drug metabolism.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may reduce Iberogast efficacy. - Antidiarrheal agents: additive antispasmodic effect could cause constipation. - Other herbal supplements with similar constituents: risk of cumulative effects.